All-in-One Device Increases Bedside Spirometry Testing
By HospiMedica International staff writers Posted on 19 Jun 2017 |
Image: The EasyOne Air portable, connected spirometry device (Photo courtesy of ndd Medical Technologies).
A new spirometry solution helps primary care physicians conduct lung function testing at the point of care (POC).
The EasyOne Air is a portable, connected spirometry device that requires no calibration, warm-up time, or maintenance. An intuitive, full-color touch screen display ensures accurate and immediate results through real-time curves and parameters. The device connects via USB to a computer for direct printing and downloading, with an added option of portability through a secure Bluetooth connection, providing seamless integration to the patients’ electronic medical record (EMR) via EasyOne Connect, a platform for all EasyOne point-of-care solutions.
EasyOne Air is powered by propriety ultrasound flow technology that anticipates interfering variables, allowing it to function independently of gas composition, pressure, temperature, and humidity, thus ensuring a consistent, standardized test that is based on American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. Test types include FVC, FVL, SVC, MVV, and Pre/Post Testing. EasyOne Air is a product of ndd Medical Technologies (Zurich, Switzerland), and has been approved by the U.S. Food and Drug Administration (FDA).
“EasyOne Air is a flexible and reliable tool for healthcare professionals to accurately diagnose lung health. This new model includes ndd’s TrueFlow technology for the most accurate way to diagnose the growing number of patients suffering from COPD and other chronic lung diseases,” said Georg Harnoncourt, CEO of ndd Medical Technologies. “The earlier a physician can diagnose a patient, the faster they can offer treatment. The sooner a patient begins treatment, the better their quality of life.”
Spirometry is the most common pulmonary function test (PFT); it measures lung function, specifically the volume and/or flow of air inhaled and exhaled, which is helpful in assessing breathing patterns that identify conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Spirometry generates pneumotachograph charts that plot the volume and flow of air coming in and out of the lungs from one inhalation and one exhalation.
Related Links:
ndd Medical Technologies
The EasyOne Air is a portable, connected spirometry device that requires no calibration, warm-up time, or maintenance. An intuitive, full-color touch screen display ensures accurate and immediate results through real-time curves and parameters. The device connects via USB to a computer for direct printing and downloading, with an added option of portability through a secure Bluetooth connection, providing seamless integration to the patients’ electronic medical record (EMR) via EasyOne Connect, a platform for all EasyOne point-of-care solutions.
EasyOne Air is powered by propriety ultrasound flow technology that anticipates interfering variables, allowing it to function independently of gas composition, pressure, temperature, and humidity, thus ensuring a consistent, standardized test that is based on American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. Test types include FVC, FVL, SVC, MVV, and Pre/Post Testing. EasyOne Air is a product of ndd Medical Technologies (Zurich, Switzerland), and has been approved by the U.S. Food and Drug Administration (FDA).
“EasyOne Air is a flexible and reliable tool for healthcare professionals to accurately diagnose lung health. This new model includes ndd’s TrueFlow technology for the most accurate way to diagnose the growing number of patients suffering from COPD and other chronic lung diseases,” said Georg Harnoncourt, CEO of ndd Medical Technologies. “The earlier a physician can diagnose a patient, the faster they can offer treatment. The sooner a patient begins treatment, the better their quality of life.”
Spirometry is the most common pulmonary function test (PFT); it measures lung function, specifically the volume and/or flow of air inhaled and exhaled, which is helpful in assessing breathing patterns that identify conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Spirometry generates pneumotachograph charts that plot the volume and flow of air coming in and out of the lungs from one inhalation and one exhalation.
Related Links:
ndd Medical Technologies
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration